Viene descritto un disturbo ematologico insolito in un paziente con malattia di Hodgkin in stadio avanzato. Un reperto isolato di ipofibrinogenemia, senza diatesi emorragica e senza evidenza di coagulazione intravascolare disseminata, ritornò alla norma dopo trattamento positivo della malattia di Hodgkin.
Get full access to this article
View all access options for this article.
References
1.
AndersonL., NissonI. M., OhowB.: Fibrinolytic activity in man during surgery.Thromb. Diath. Hemorrh. (Stuttg.), 7: 391–403, 1962.
2.
BiggsR., MacfarlaneR. G.: Human blood coagulation and its disorders. pp. 189, Blackwell Scientific Publications, Oxford, 1963.
3.
HardistyR. M., IngramG. I. C.: Bleeding disorders and management. pp. 285. Blackwell Scientific Publications, Oxford, 1965.
4.
IvyI. S., ShapiroP. F., MelnickP.: The bleeding tendency in jaundice.Surg. Gynec. Obstet., 60: 781–784, 1935.
5.
JurgensR., TrautweinH.: über Fibrinopenie (Fibrinogenopenie) beim Erwachsenen nebst Bemerkungen über die Herkunft des Fibrinogens.Dtsch. Arch. Klin. Med., 169: 28–29, 1930.
6.
LakiK., LorandL.: On the solubility of the fibrin clots.Science,108: 280, 1948.
7.
LeavellB. S., ThorpO. A.Jr.: Fundamentals of clinical hematology.2nd ed., pp. 560. W. B. Saunders Company, Philadelphia and London, 1966.
8.
MerskeyC., LalzeriP., JohnsonA. J.: A rapid simple sensitive method for measuring fibrinolytic split products in human serum.Proc. Soc. Exp. Biol. Med. (N.Y.), 131: 871–875, 1969.
9.
NiewiarowskiS., GurewichV.: Laboratory identification of intravascular coagulation. The serial dilution protamine sulfate test for the detection of fibrin monomer and fibrin degradation products.J. lab. Blin. Med., 77: 665–676, 1971.
